Cadrenal Therapeutics, Inc. Common Stock
CVKD •
Sell Open
Signal type
Sell
Status
Open
Open Price
$6.10
Stop Loss
$8.40
Performance
21.48%
Days Open
23
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 23, 2026
Open Price $6.10
Stop Loss $8.40
Timespan Day
Company Profile
Name Cadrenal Therapeutics, Inc. Common Stock
Ticker CVKD
Market Cap $22.95M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $4.79
List Date Jan 20, 2023
Description
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Website Open Company Website